SERI® Surgical Scaffold
Soft tissue support and repair (plastic/reconstructive surgery)
ApprovedActive
Key Facts
Indication
Soft tissue support and repair (plastic/reconstructive surgery)
Phase
Approved
Status
Active
Company
About Sofregen Medical
Sofregen Medical is a private biotechnology company leveraging a proprietary silk protein platform to create a portfolio of implantable and injectable biomaterials for soft tissue regeneration. Founded in 2013 and headquartered in Medford, Massachusetts, the company has two FDA-cleared products: SERI® Surgical Scaffold and Silk Voice® Injectable Implant. Sofregen is advancing its pipeline to develop next-generation silk-based fillers and devices for the aesthetic and reconstructive surgery markets, aiming to become a leader in regenerative beauty solutions.
View full company profile